Henke P K, Cardneau J D, Welling T H, Upchurch G R, Wakefield T W, Jacobs L A, Proctor S B, Greenfield L J, Stanley J C
Department of Surgery, Section of Vascular Surgery, University of Michigan, 1500 E. Medical Center Dr., Ann Arbor, MI 48109-0329, USA.
Ann Surg. 2001 Oct;234(4):454-62; discussion 462-3. doi: 10.1097/00000658-200110000-00005.
To define the relevance of treating renal artery aneurysms (RAAs) surgically.
Most prior definitions of the clinical, pathologic, and management features of RAAs have evolved from anecdotal reports. Controversy surrounding this clinical entity continues.
A retrospective review was undertaken of 168 patients (107 women, 61 men) with 252 RAAs encountered over 35 years at the University of Michigan Hospital. Aneurysms were solitary in 115 patients and multiple in 53 patients. Bilateral RAAs occurred in 32 patients. Associated diseases included hypertension (73%), renal artery fibrodysplasia (34%), systemic atherosclerosis (25%), and extrarenal aneurysms (6.5%). Most RAAs were saccular (79%) and noncalcified (63%). The main renal artery bifurcation was the most common site of aneurysms (60%). RAAs were often asymptomatic (55%), with a diagnosis made most often during arteriographic study for suspected renovascular hypertension (42%).
Surgery was performed in 121 patients (average RAA size 1.5 cm), including 14 patients undergoing unilateral repair with contralateral RAA observation. The remaining 47 patients (average RAA size 1.3 cm) were not treated surgically. Operations included aneurysmectomy and angioplastic renal artery closure or segmental renal artery reimplantation, aneurysmectomy and renal artery bypass, and planned nephrectomy for unreconstructable renal arteries or advanced parenchymal disease. Eight patients underwent unplanned nephrectomy, being considered a technical failure of surgical therapy. Dialysis-dependent renal failure occurred in one patient. There were no perioperative deaths. Late follow-up (average 91 months) was available in 145 patients (86%). All but two arterial reconstructions remained clinically patent. Secondary renal artery procedures included percutaneous angioplasty, branch embolization, graft thrombectomy, and repeat bypass for late aneurysmal change of a vein conduit. Among 40 patients with clearly documented preoperative and postoperative blood pressure measurements, 60% had a significant decline in blood pressure after surgery while taking fewer antihypertensive medications. Late RAA rupture did not occur in the nonoperative patients, but no lessening of this group's hypertension was noted.
Surgical therapy of RAAs in properly selected patients provides excellent long-term clinical outcomes and is often associated with decreased blood pressure.
明确手术治疗肾动脉动脉瘤(RAA)的相关性。
此前关于RAA临床、病理及治疗特征的大多数定义均源自个案报道。围绕这一临床实体的争议仍在继续。
对密歇根大学医院35年间收治的168例患者(107例女性,61例男性)的252个RAA进行回顾性研究。115例患者的动脉瘤为单发,53例为多发。32例患者存在双侧RAA。相关疾病包括高血压(73%)、肾动脉纤维发育不良(34%)、系统性动脉粥样硬化(25%)及肾外动脉瘤(6.5%)。大多数RAA为囊状(79%)且无钙化(63%)。肾动脉主分叉是最常见的动脉瘤部位(60%)。RAA通常无症状(55%),最常在因疑似肾血管性高血压而行血管造影检查时被诊断(42%)。
121例患者接受了手术(RAA平均大小为1.5 cm),其中14例患者接受单侧修复并对侧RAA观察。其余47例患者(RAA平均大小为1.3 cm)未接受手术治疗。手术方式包括动脉瘤切除术及血管成形术肾动脉闭合或节段性肾动脉再植术、动脉瘤切除术及肾动脉搭桥术,以及因肾动脉无法重建或实质性疾病进展而计划行肾切除术。8例患者接受了非计划肾切除术,被视为手术治疗的技术失败。1例患者出现依赖透析的肾衰竭。无围手术期死亡。145例患者(86%)获得了晚期随访(平均91个月)。除2例动脉重建外,其余均保持临床通畅。二次肾动脉手术包括经皮血管成形术、分支栓塞术、移植物血栓切除术,以及因静脉导管晚期动脉瘤样改变而行再次搭桥术。在40例术前和术后血压测量记录明确的患者中,60%术后血压显著下降且服用的降压药物减少。非手术治疗患者未发生晚期RAA破裂,但该组患者的高血压未见减轻。
对经过适当选择的患者进行RAA手术治疗可提供良好的长期临床疗效,且常伴有血压下降。